UCSF 41st Annual Advances in Heart Disease 2024

Overview

Experience the leading edge of cardiology with the UCSF 41st Annual Advances in Heart Disease 2024, a comprehensive, evidence-based course designed to keep you ahead in the dynamic field of cardiovascular medicine. Delivered by distinguished faculty and experts from across North America and the University of California, San Francisco, this program covers groundbreaking developments as well as essential updates impacting daily clinical practice.

Sessions are available for on-demand viewing, enabling you to benefit from world-class medical learning — accessible anytime, anywhere. Expand your skills in diagnosis, management, and prevention of cardiovascular disease while advancing patient care in your practice.

Learning Objectives

After completing this course, participants will be able to:

• Apply the latest evidence-based strategies for managing coronary heart disease, hypertension, lipid disorders, diabetes, systolic and diastolic heart failure, atrial fibrillation and flutter, STEMI and Non-STEMI, and thromboembolic disease.
• Refine clinical decision-making in ablation procedures for atrial fibrillation, atrial flutter, and ventricular tachycardia.
• Evaluate appropriate use and timing of percutaneous coronary interventions.
• Enhance patient outcomes by utilizing optimal anti-platelet and anti-coagulation therapies for cardiovascular diseases.
• Identify and implement risk stratification tools for cardiovascular disease.
• Optimize management strategies for peripheral artery disease.
• Recognize differences in pathophysiology and treatment options among diverse racial and ethnic groups.
• Manage cardiovascular complications of COVID-19 effectively.

Topics

This course features in-depth sessions capturing the latest and most essential subjects in cardiology today:

• December 6 AM Session.mp4
• December 6 PM Session.mp4
• December 7 AM Session.mp4
• December 7 PM Session.mp4
• December 8 AM Session.mp4
• Welcome and Symposium Overview
• Frontiers in Interventional Cardiology
• Myocardial Infarction Without Obstructive Coronary Disease. What to Do?
• Complete Revascularization vs Culprit Only Revascularization: Understanding Each Strategy and When to Perform Each Approach
• Orbita vs Orbita 2: Update on PCI for Stable CAD
• 2024 Updates on the Management of Valve Disease
• Surgical Management of Type A Aortic Dissection
• Circulatory Support in Cardiogenic Shock: New Data and a New Era?
• Managing Heart Failure
• New Drugs and Devices Coming Down Pipeline for Heart Failure
• Genetic Testing for Heart Failure, Who Should Be Tested and What are We Looking For?
• HFrEF Management
• HFpEF Management
• Approach to and Management of Hypertrophic Cardiomyopathy
• Approach to and Management of Cardiac Amyloid
• Advances and Controversies in Electrophysiology
• Use and Misuse of Antiarrhythmic Drugs in 2025
• Extravascular Pacemakers and ICDs: Where Have All the Leads Gone?
• Conduction System Pacing: Benefits, Outcomes and Risks
• Arrhythmogenic Cardiomyopathy
• What to Do with Incidentally Detected Atrial Fibrillation
• PVCs and non-Sustained VT. When to Worry.
• Achieving a Successful Ablation. Patient Selection and Outcomes.
• Cardiovascular Risk Reduction and Prevention
• How Failed Diabetes Drugs Led to a Revolution in Diabetes and Heart Failure Care
• New Prediction Tools from the AHA for Risk Assessment of Cardiovascular Disease
• Cardiovascular Disease in Type 1 Diabetes
• Pulmonary Hypertension, Contemporary Management and When to Refer
• Understanding and Managing Cardiovascular Risk
• Sex Diversity in Heart-Liver-Metabolic Axis Risks and Outcomes
• PDE-5 Inhibitors for Erectile Dysfunction: Do They Have Cardiovascular Protective Properties?
• The Interplay of Cardiovascular and Kidney Disease
• Insights from Basic Science to Advance Understanding of Heart Failure
• Weight Loss Drugs and Heart Health
• Management of Stroke – Updates

Target Audience

This course is designed for healthcare professionals invested in current and comprehensive cardiology education, including:

• Cardiovascular specialists
• Practicing cardiologists
• Internists
• Family physicians
• Cardiovascular and critical care physician assistants
• Cardiovascular and critical care nurses

Speakers

Engage with a collaborative panel of leading experts dedicated to advancing cardiovascular medicine:

• Peter Ganz, MD – Course Chair and session moderator
• Lucas Zier, MD, MS – Interventional Cardiology Session Chair
• Jonathan Davis, MD, MPH – Heart Failure Session Chair
• Nora Goldschlager, MD – Electrophysiology Session Chair
• Krishan Soni, MD, MBA – Interventional Cardiology Faculty
• Ada Ip, MD – Interventional Cardiology Faculty
• Sammy Elmariah, MD, MPH – Valve Disease Faculty
• Ramin Beygui, MD – Aortic Dissection Faculty
• Connor O’Brien, MD – Circulatory Support Faculty
• Liviu Klein, MD, MS – Heart Failure Faculty
• Julianne Wojciak, LGCG, MS – Genetics in Heart Failure Faculty
• Jacqueline DesJardin, MD – HFpEF Management Faculty
• Theodore Abraham, MD – Hypertrophic Cardiomyopathy Faculty
• Mandar Aras, MD, PhD – Cardiac Amyloid Faculty
• Gregory Marcus, MD, MAS – Electrophysiology Faculty
• Adam Oesterle, MD – Electrophysiology Faculty
• Joshua Moss, MD – Conduction System Pacing Faculty
• Melvin Scheinman, MD – Arrhythmogenic Cardiomyopathy Faculty
• Cara Pellegrini, MD – Atrial Fibrillation Management
• Edward Gerstenfeld, MD, MS – Ventricular Tachycardia Faculty
• Thomas Dewland, MD – Ablation Faculty
• Steven Nissen, MD – Keynote Speaker, Diabetes and Heart Failure
• Robert Eckel, MD – Diabetes and Heart Disease Faculty
• Marc Simon, MD, MS – Pulmonary Hypertension Faculty
• Susan Cheng, MD, MMSc, MPH – Sex Diversity in Cardiovascular Risk
• Robert Kloner, MD, PhD – Erectile Dysfunction and Heart Health
• Julio Lamprea Montealegre, MD, PhD, MPH – Cardiovascular-Kidney Disease Interplay
• Arun Padmanabhan, MD, PhD – Basic Science and Heart Failure Faculty
• Martha Gulati, MD, MS – Weight Loss Drugs and Heart Health
• Lauren Patrick, MD – Stroke Management Updates

Our speakers blend clinical expertise with academic distinction, presenting advanced, up-to-date knowledge for today’s cardiovascular professionals.

Educational content only. Not medical advice.